[Foundations of the therapy of inoperable malignomas and hemoblastoses].
D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007114:Immunization; D007167:Immunotherapy; D007938:Leukemia / Q000188:drug therapy*; D008938:Mitosis; D009369:Neoplasms / Q000188:drug therapy* / Q000601:surgery; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D014750:Vincristine; D014747:Vinblastine
Grundlagen der Therapie inoperabler Malignome und Hämoblastosen